| (210) | Number of the EPO application | 16715583 |
| (220) | Filing date of the EPO application | 2016.04.13 |
| (80) | EPO patent specification publication (B) | EPB nr. 46/2023, 2023.11.15 |
| (110) | EPO patent number | 3283521 |
| (11) | Number of the document | MD 3283521 T2 |
| (21) | Number of the application | e 2018 0164 |
| (71) | Name(s) of applicant(s), code of the country | ASTELLAS PHARMA INC., JP;
TRON - TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITÄTSMEDIZIN DER JOHANNES GUTENBERG- UNIVERSITÄT MAINZ GEMEINNÜTZIGE GMBH, DE; |
| (72) | Name(s) of inventor(s), code of the country | SAHIN Ugur, DE;
TÜRECI Özlem, DE;
WALTER Korden, DE;
KREUZBERG Maria, DE;
MITNACHT-KRAUS Rita, DE;
LE GALL Fabrice, DE;
JACOBS Stefan, DE; |
| (73) | Name(s) of owner(s), code of the country | ASTELLAS PHARMA INC., JP;
TRON - TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITÄTSMEDIZIN DER JOHANNES GUTENBERG- UNIVERSITÄT MAINZ GEMEINNÜTZIGE GMBH, DE; |
| (54) | Title of the invention | Drug conjugates comprising antibodies against CLAUDIN 18.2 |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | C07K 16/28 (2006.01.01); C07K 16/30 (2006.01.01); A61K 47/68 (2017.01.01); A61P 35/00 (2006.01.01); A61K 31/40 (2006.01.01) |
| (19) | Country | JP |
| (41) | Date of publication of the application | 2018.04.30 |
| (49) | Date of publication of the translation of the validated European patent specification | 2024.03.31 |
| (30) | Priority | PCT/EP2015/0582, 2015.04.15, WO |
| (74) | Patent attorney | (Procedură) FOCŞA Valentin, bd. Renaşterii Naţionale, No. 6, of. 08, MD-2024, mun. Chişinău, Republica Moldova |
| (86) | International application | PCT/EP2016/058056, 2016.04.13 |
| (87) | International publication | WO 2016/166122, 2016.10.20 |